| Multiple | Now | Sector median | Where it sits |
|---|---|---|---|
| P/E | −7.8× | −1.7× | |
| Price / Book | 7.1× | 2.0× | |
| Price / Sales | 16.9× | 3.9× | |
| Price / Free cash flow | −7.8× | −1.5× | |
| EV / EBITDA | −8.2× | −1.2× | |
| Earnings yield | −12.8% | −14.4% | |
| Free cash flow yield | −12.7% | −9.9% |
| Company | Price | Change | Mkt cap (USD) | P/E | ROE | 1Y |
|---|---|---|---|---|---|---|
LLNYSE:LLY |
| $1,299.06 |
| +4.73% |
| $1.22T |
| 56.6× |
| 77.8% |
| +15.2% |
JNNYSE:JNJJohnson & Johnson · 🇺🇸 NYSE | $259.55 | +2.27% | $625.49B | 22.8× | 32.9% | +32.1% |
ABNYSE:ABBVAbbVie Inc · 🇺🇸 NYSE | $289.35 | +2.36% | $511.32B | 118.2× | −129.2% | +24.6% |
UNNYSE:UNHUnitedHealth Group Inc · 🇺🇸 NYSE | $420.88 | +3.44% | $377.78B | 30.3× | 12.8% | +14.1% |
MRNYSE:MRKMerck & Co Inc · 🇺🇸 NYSE | $148.23 | +3.20% | $365.71B | 19.4× | 34.7% | +71.2% |
NVNYSE:NVSNovartis AG · 🇺🇸 NYSE | $153.46 | +2.17% | $282.9B | 19.7× | 30.5% | +14.9% |
AZNYSE:AZNAstraZeneca PLC · 🇺🇸 NYSE | $168.66 | +2.87% | $261.58B | 24.8× | 21.1% | −2.4% |
TMNYSE:TMOThermo Fisher Scientific Inc · 🇺🇸 NYSE | $684.34 | +0.73% | $253.03B | 37.3× | 12.6% | +26.6% |
AMNAS:AMGNAmgen Inc · 🇺🇸 NAS | $434.94 | +2.35% | $235.14B | 29.8× | 89.1% | +43.7% |
GINAS:GILDGilead Sciences Inc · 🇺🇸 NAS | $156.12 | +1.99% | $193.58B | 22.3× | 37.5% | +29.9% |
